{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T12:40:59Z","timestamp":1777380059893,"version":"3.51.4"},"reference-count":40,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["AIDS Research and Human Retroviruses"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:p>\n                    People living with HIV (PLHIV) have an increased risk of hematologic malignancies (HMs). We aimed to characterize HMs among PLHIV at Karolinska University Hospital, Stockholm, Sweden. We studied all PLHIV receiving care at our center between 2004 and 2018. Data were retrieved retrospectively from InfCareHIV database and medical records. Around 3,484 patients received HIV care for a total of 22,903 person-years (py) with median follow-up of 7.6 years. HMs were identified in 43 patients with 30 cases of non-Hodgkin lymphoma (NHL), 9 cases of Hodgkin lymphoma (HL), 2 multicentric Castleman's disease, and 1 case each of myeloma and myelodysplastic syndrome. The incidence rate of NHL was 88\/10\n                    <jats:sup>5<\/jats:sup>\n                    py and HL 39.6\/10\n                    <jats:sup>5<\/jats:sup>\n                    py. The incidence of NHL declined 2004\u20132010 versus 2011\u20132018 (180.8 vs. 40.1\/10\n                    <jats:sup>5<\/jats:sup>\n                    py;\n                    <jats:italic toggle=\"yes\">p<\/jats:italic>\n                    \u2009=\u2009.001). Median time from HIV diagnosis to malignancy was shorter in NHL compared with HL (1.2 years vs. 8.9 years;\n                    <jats:italic toggle=\"yes\">p<\/jats:italic>\n                    \u2009=\u2009.01) and effective HIV treatment was less common in NHL (33% vs. 100%;\n                    <jats:italic toggle=\"yes\">p<\/jats:italic>\n                    \u2009&lt;\u2009.001). The 5-year survival rate of NHL was 59% and HL 43%, significantly lower compared with lymphoma survival in the general population in Sweden. In the era of effective antiretroviral therapy (ART), the incidence rate of lymphoma was more than five times higher in PLHIV and 5-year survival significantly inferior. Efforts for earlier identification of HIV-infected individuals are likely to affect the incidence of NHL. Additionally, an effective screening for clinical and laboratory signs of HL in PLHIV on ART should be introduced to improve identification and survival of HL in this population.\n                  <\/jats:p>","DOI":"10.1089\/aid.2021.0020","type":"journal-article","created":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T12:33:34Z","timestamp":1634301214000},"page":"135-142","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Incidence, Treatment, and Outcome of HIV-Associated Hematologic Malignancies in People Living with HIV in Sweden"],"prefix":"10.1177","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9128-8107","authenticated-orcid":false,"given":"Oscar","family":"Kieri","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden."},{"name":"Division of Infectious diseases, Department of Medicine Huddinge, Karolinska Institute, Stockholm, Sweden."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaetano","family":"Marrone","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden."},{"name":"Division of Infectious diseases, Department of Medicine Huddinge, Karolinska Institute, Stockholm, Sweden."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"S\u00f6nnerborg","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden."},{"name":"Division of Infectious diseases, Department of Medicine Huddinge, Karolinska Institute, Stockholm, Sweden."},{"name":"Division of Clinical Microbiology, Department of Laboratory Medicine ANA Futura Laboratory, Karolinska Institute, Stockholm, Sweden."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Nowak","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden."},{"name":"Division of Infectious diseases, Department of Medicine Huddinge, Karolinska Institute, Stockholm, Sweden."},{"name":"Division of Clinical Microbiology, Department of Laboratory Medicine ANA Futura Laboratory, Karolinska Institute, Stockholm, Sweden."},{"name":"The Laboratory for Molecular Infection Medicine Sweden MIMS, Ume\u00e5 University, Ume\u00e5, Sweden."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2022,2,4]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju503"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000327"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1615896"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61050-2"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix392"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(17)30125-X"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.22.1823"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000428"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3282f2705d"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0129550"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000238411.75324.59"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit497"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000382"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-471"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001622-200209000-00009"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-11-681411"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(01)01020-8"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32833a0961"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1086\/656416"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-16-0595"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djt158"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12431"},{"key":"e_1_3_4_24_2","unstructured":"National Quality Registry for HIV (InfCare HIV\u00ae). Stockholm Regional Council 2019. Available at https:\/\/qrcstockholm.se\/register\/anslutna-register\/infcarehiv-och-infcarehepatit\/ accessed January20 2020."},{"key":"e_1_3_4_25_2","first-page":"1860","article-title":"Report of the Committee on Hodgkin's Disease Staging Classification","volume":"31","author":"Carbone PP","year":"1971","unstructured":"Carbone PP, , Kaplan HS, , Musshoff K, , Smithers DW, , Tubiana M: Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res, 1971; 31:1860\u20131861.","journal-title":"Cancer Res"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309303291402"},{"key":"e_1_3_4_27_2","unstructured":"Socialstyrelsen. Statistical databases: The National Board of Health and Welfare. Available at https:\/\/sdb.socialstyrelsen.se\/if_can\/val_eng.aspx accessed January20 2020."},{"key":"e_1_3_4_28_2","unstructured":"Nationella kvalitetsregistret f\u00f6r lymfom: \u00c5rsrapport fr\u00e5n Nationell kvalitetsregistret f\u00f6r lymfom diagnosperioden 2000\u20132019. Regionala Cancercentrum. 2020. Available at https:\/\/cancercentrum.se\/globalassets\/cancerdiagnoser\/blod-lymfom-myelom\/lymfom\/rapporter\/lymfomarsrapport2000-2019.pdf accessed November21 2020."},{"key":"e_1_3_4_29_2","unstructured":"NORDCAN: Cancer Incidence Mortality Prevalence and Survival in the Nordic Countries Version 8.2. Association of the Nordic Cancer Registries. Danish Cancer Society.; 2019. Available at https:\/\/www-dep.iarc.fr\/NORDCAN\/english\/frame.asp accessed January20 2020."},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(18)30360-6"},{"key":"e_1_3_4_31_2","first-page":"1","article-title":"Antiretroviral treatment for HIV infection: Swedish recommendations 2019","volume":"52","author":"Eriksen J","year":"2020","unstructured":"Eriksen J, , Carlander C, , Albert J, et al.: Antiretroviral treatment for HIV infection: Swedish recommendations 2019. Infect Dis (Lond), 2020; 52:1\u201335.","journal-title":"Infect Dis (Lond)"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-05-024109"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-08-301531"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000980"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32895"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3282f47082"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12200"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13090"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2011.0259"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328330f62d"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy542"}],"container-title":["AIDS Research and Human Retroviruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/aid.2021.0020","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/aid.2021.0020","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/aid.2021.0020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T09:16:18Z","timestamp":1777367778000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1089\/aid.2021.0020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["10.1089\/aid.2021.0020"],"URL":"https:\/\/doi.org\/10.1089\/aid.2021.0020","relation":{},"ISSN":["0889-2229","1931-8405"],"issn-type":[{"value":"0889-2229","type":"print"},{"value":"1931-8405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2]]}}}